Clinical trial
Risperidone Augmentation for Treatment-Resistant Aggression in ADHD
NCT00297739 · Armenteros, Jorge L., M.D., P.A., Other · Completed
Key facts
| NCT number | NCT00297739 |
|---|---|
| Title | Risperidone Augmentation for Treatment-Resistant Aggression in ADHD |
| Official title | Risperidone Augmentation for Treatment-Resistant Aggression in ADHD |
| Lead sponsor | Armenteros, Jorge L., M.D., P.A., Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Aggression |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 25 |
| Start date | Jan 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Mar 1, 2006 |
| Last update posted | Mar 16, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: